Our Faculty

Scientists collaberate while working at a computer

With 130+ physician and research faculty members, our division is one of the largest in the country. Our faculty members participate in every facet of cancer prevention, patient care, survivorship, mentorship, and research on cancer and related diseases.

This is unpublished

Physician & Research Faculty Profiles 

 

Notable Faculty achievements

  • Faculty have been elected by their peers to lead the American Society for Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research, the American Society for Transplantation and Cellular Therapy, the World Marrow Donor Association, the American Society for Blood and Marrow Transplantation, and the National Cancer Institute’s Leukemia and Lymphoma Steering Committees.
  • Many faculty members have been chosen to determine standardized cancer care guidelines through the National Comprehensive Cancer Network.
  • Faculty have been editors-in-chief of major textbooks and professional journals.
  • Faculty published more than 400 peer-reviewed journal articles in 2019.
  • Our faculty continue to be chosen by their peers for Seattle Magazine’s Best Doctors list. In 2022 twelve faculty members were honored.
  • Sixteen faculty members hold endowed chairs. 
  • Our division was founded by Dr. E. Donnall Thomas, who received the Nobel Prize for his work in developing bone marrow transplantation.

Faculty news

2026 Top Doctors, Physician Assistants and Nurses
Congratulations to those who made the 2026 Seattle Met’s annual list of the best health care professionals in the region.
Molecular switch to help prostate cancer change its biology
Recent research shows that the same mechanisms that aggressive prostate cancer cells manipulate to elude therapy can be used against them, forcing them to shapeshift back into their more treatable form.
Lynn Synmonds receives Career Development Award
She has received a prestigious American Society of Clinical Oncology Career Development Award for work on a new biomarker for triple-negative breast cancer.